Circulating miR-30b-5p levels in plasma as a novel potential biomarker for early detection of breast cancer
2021 · ESMO Open · 33 citations
https://doi.org/10.1016/j.esmoop.2020.100039
I
Iris Garrido‐Cano
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
31
Papers
517
Citations
14
h-index
15
i10-index
Iris Garrido‐Cano is an academic researcher from Universitat de València. The author has contributed to research in topics: MicroRNA in disease regulation & Cancer-related molecular mechanisms research & Circular RNAs in diseases. The author has an h-index of 14, co-authored 27 publications.
ORCID: 0000-0002-1211-473XPapers by this author
worksMicroRNAs as a clue to overcome breast cancer treatment resistance
2021 · Cancer and Metastasis Reviews · 30 citations
https://doi.org/10.1007/s10555-021-09992-0
Clinical decision impact of HER2DX, an algorithm-powered genomic diagnostic in early-stage HER2-positive breast cancer: results from a prospective real-world study
2025 · ESMO Real World Data and Digital Oncology · 9 citations
https://doi.org/10.1016/j.esmorw.2025.100123
Involvement of microRNAs-449/FASN axis in response to trastuzumab therapy in HER2-positive breast cancer
2025 · Molecular Medicine · 2 citations
https://doi.org/10.1186/s10020-025-01163-z
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat